{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:55:09Z","timestamp":1773060909413,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12026-016-8828-4","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T01:02:58Z","timestamp":1468803778000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An idiopathic thrombocytopenic purpura with polyneuropathy"],"prefix":"10.1007","volume":"65","author":[{"given":"Valeria","family":"Katchan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"8828_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/WNL.41.9.1517","volume":"41","author":"K Greenberg Michael","year":"1991","unstructured":"Greenberg Michael K, Sonoda T. Mononeuropathy multiplex complicating idiopathic thrombocytopenic purpura. Neurology. 1991;41:1517\u2013818.","journal-title":"Neurology"},{"key":"8828_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.1964.03070190074023","volume":"190","author":"A Silverstein","year":"1964","unstructured":"Silverstein A. Neuropathy in hemophilia. JAMA. 1964;190:554\u20135.","journal-title":"JAMA"},{"key":"8828_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/archneurpsyc.1952.02320240094010","volume":"68","author":"NH Bigelow","year":"1952","unstructured":"Bigelow NH, Graves RN. Peripheral nerve lesions in hemorrhagic diseases. Arch Neurol Psychiat. 1952;68:819\u201330.","journal-title":"Arch Neurol Psychiat"},{"key":"8828_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00005072-196410000-00011","volume":"23","author":"A Brun","year":"1964","unstructured":"Brun A, Caviness V, Rudnick P, Tayler HR. Hemorrhages into peripheral nerves in association with leukemia. J Neuropathol Exp Neurol. 1964;23:719\u201325.","journal-title":"J Neuropathol Exp Neurol"},{"key":"8828_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/bmj.289.6436.18","volume":"289","author":"FT Cordinegley","year":"1984","unstructured":"Cordinegley FT, Crawford GPM. Ulnar nerve palsy in the haemophiliac due to intraneural haemorrhage. Br Med J. 1984;289:18\u20139.","journal-title":"Br Med J"},{"key":"8828_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000116893","volume":"33","author":"S Miyao","year":"1993","unstructured":"Miyao S, Takano A, Teramoto J, Fujitake S, Hashizume Y. Oculomotor nerve palsy due to intraneural hemorrhage in idiopathic thrombocytopenic purpura: a case report. Eur Neurol. 1993;33:20\u20132.","journal-title":"Eur Neurol"},{"key":"8828_CR7","first-page":"847","volume":"43","author":"J Gianpolo Antony","year":"1993","unstructured":"Gianpolo Antony J, Giuliani Michael J. ITP and neuropathy. To the editor. Neurology. 1993;43:847.","journal-title":"Neurology"},{"issue":"3","key":"8828_CR8","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.7205\/MILMED-D-12-00306","volume":"178","author":"IM Ward","year":"2013","unstructured":"Ward IM, Fewell AE, Ferraro DM, Morris MJ. Concurrent acute motor and sensory axonal neuropathy and immune thrombocytopenic purpura. Mil Med. 2013;178(3):e367.","journal-title":"Mil Med"},{"key":"8828_CR9","first-page":"3","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:3\u20137.","journal-title":"Isr Med Assoc J"},{"key":"8828_CR10","first-page":"8","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, Freire de Carvalho J, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:8\u201312.","journal-title":"Isr Med Assoc J"},{"key":"8828_CR11","first-page":"13","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Eric Gershwin M. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J. 2008;10:13\u20139.","journal-title":"Isr Med Assoc J"},{"key":"8828_CR12","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barre\u00b4 syndrome. Lancet. 2005;366:1653\u201366.","journal-title":"Lancet"},{"key":"8828_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2796.2005.01479.x","volume":"257","author":"N Sato","year":"2005","unstructured":"Sato N, Kamata T, Akiyama N, Kuwana M, Kanda T. Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura. J Intern Med. 2005;257:473\u20137.","journal-title":"J Intern Med"},{"key":"8828_CR14","doi-asserted-by":"publisher","unstructured":"Harati Y, Bosch EP. Disorders of peripheral nerves. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Bradley\u2019s neurology in clinical practice, vol. 2, 5th ed. Philadelphia: Butterworth-Heinemann Elsevier; 2008. p. 2288\u20132296.","DOI":"10.1016\/B978-0-7506-7525-3.50118-7"},{"key":"8828_CR15","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"8828_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Bergh Van den","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol. 2010;17:356.","journal-title":"Eur J Neurol"},{"key":"8828_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0b013e31824de293","volume":"78","author":"HS Patwa","year":"2012","unstructured":"Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78:1009.","journal-title":"Neurology"},{"key":"8828_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","volume":"359","author":"B Godeau","year":"2002","unstructured":"Godeau B, Chevret S, Varet B, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002;359:23.","journal-title":"Lancet"},{"key":"8828_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"R Hughes","year":"2001","unstructured":"Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195.","journal-title":"Ann Neurol"},{"key":"8828_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ana.410360607","volume":"36","author":"PJ Dyck","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994;36:838.","journal-title":"Ann Neurol"},{"key":"8828_CR21","first-page":"CD001797","volume":"12","author":"F Eftimov","year":"2013","unstructured":"Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;12:CD001797.","journal-title":"Cochrane Database Syst Rev"},{"key":"8828_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","volume":"107","author":"B Godeau","year":"1999","unstructured":"Godeau B, Caulier MT, Decuypere L, et al. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1\u00a0g\/kg b.w. Br J Haematol. 1999;107:716.","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"8828_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2249.2009.04026.x","volume":"158","author":"R Schwartz-Albiez","year":"2009","unstructured":"Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol. 2009;158(Suppl 1):43\u201350.","journal-title":"Clin Exp Immunol"},{"key":"8828_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/intimm\/11.8.1247","volume":"11","author":"Y Shoenfeld","year":"1999","unstructured":"Shoenfeld Y, Fishman P. Gamma-globulin inhibits tumour spread in mice. Int Immunol. 1999;11:1247\u201351.","journal-title":"Int Immunol"},{"key":"8828_CR25","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.10905","volume":"95","author":"S Shapiro","year":"2002","unstructured":"Shapiro S, Shoenfeld Y, Gilburd B, et al. Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer. 2002;95:2032\u20137.","journal-title":"Cancer"},{"key":"8828_CR26","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386.","journal-title":"Blood"},{"key":"8828_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1182\/blood-2011-12-309153","volume":"120","author":"W Ghanima","year":"2012","unstructured":"Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960.","journal-title":"Blood"},{"key":"8828_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"JN George","year":"1996","unstructured":"George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3.","journal-title":"Blood"},{"key":"8828_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2141.2010.08412.x","volume":"152","author":"LJ Toltl","year":"2011","unstructured":"Toltl LJ, Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol. 2011;152:52.","journal-title":"Br J Haematol"},{"key":"8828_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1212\/WNL.56.4.445","volume":"56","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445.","journal-title":"Neurology"},{"key":"8828_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jns.2013.04.015","volume":"330","author":"DR Cornblath","year":"2013","unstructured":"Cornblath DR, Gorson KC, Hughes RA, Merkies IS. Observations on chronic inflammatory demyelinating polyneuropathy: a plea for a rigorous approach to diagnosis and treatment. J Neurol Sci. 2013;330:2.","journal-title":"J Neurol Sci"},{"key":"8828_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","volume":"15","author":"KC Gorson","year":"2010","unstructured":"Gorson KC, van Schaik IN, Merkies IS, et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst. 2010;15:326.","journal-title":"J Peripher Nerv Syst"},{"key":"8828_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1212\/WNL.0b013e31824e8f84","volume":"78","author":"F Eftimov","year":"2012","unstructured":"Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78:1079.","journal-title":"Neurology"},{"key":"8828_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1529-8027.2011.00323.x","volume":"16","author":"JD Pollard","year":"2011","unstructured":"Pollard JD, Armati PJ. CIDP\u2014the relevance of recent advances in Schwann cell\/axonal neurobiology. J Peripher Nerv Syst. 2011;16:15\u201323.","journal-title":"J Peripher Nerv Syst"},{"key":"8828_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10072-010-0352-z","volume":"31","author":"P Dacci","year":"2010","unstructured":"Dacci P, Riva N, Scarlato M, et al. Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report. Neural Sci. 2010;31:829\u201331.","journal-title":"Neural Sci"},{"key":"8828_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","volume":"15","author":"Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society","year":"2010","unstructured":"Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Federation of management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. J Peripher Nerv Syst. 2010;15:295\u2013301.","journal-title":"J Peripher Nerv Syst"},{"key":"8828_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/cei.12505","volume":"178","author":"JM L\u00e9ger","year":"2014","unstructured":"L\u00e9ger JM. Immunoglobulin (IG) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN. Clin Exp Immunol. 2014;178:42\u20134.","journal-title":"Clin Exp Immunol"},{"key":"8828_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jnnp.2007.121756","volume":"79","author":"JM L\u00e9ger","year":"2008","unstructured":"L\u00e9ger JM, Viala K, Cancalon F, et al. Intravenous Immunoglobulin as short- and long-term therapy for multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. J Neural Neurosurg Psychiatry. 2008;79:93\u20136.","journal-title":"J Neural Neurosurg Psychiatry"},{"key":"8828_CR39","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/brain\/awf193","volume":"125","author":"RM Berg-Vos Van den","year":"2002","unstructured":"Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain. 2002;125:1875\u201386.","journal-title":"Brain"},{"key":"8828_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1212\/01.WNL.0000110185.23464.A1","volume":"62","author":"F Terenghi","year":"2004","unstructured":"Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy? Neurology. 2004;62:666\u20138.","journal-title":"Neurology"},{"key":"8828_CR41","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/01.WNL.0000140497.85952.FA","volume":"63","author":"S Vucic","year":"2004","unstructured":"Vucic S, Black KR, Chong PS, Cros D. Multifocal neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology. 2004;63:1264\u20139.","journal-title":"Neurology"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-016-8828-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8828-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:23:20Z","timestamp":1600914200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-016-8828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8828"],"URL":"https:\/\/doi.org\/10.1007\/s12026-016-8828-4","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}